Documents Lymphoproliferative diseases (44,9%) LEUKEMIAS (ALL, AML, CML, MDS) 33,6%

Lymphoproliferative diseases (44,9%) LEUKEMIAS (ALL, AML, CML, MDS) 33,6% LYMPHOMAS (HD, NHL) 9,8% HISTIOCYTOSIS 1,5% Solid tumours (55,1%) CNS TUMOURS 22,7% NEPHROBLASTOMA…